AARTIDRUGS - Aarti Drugs

Aarti Drugs

AARTIDRUGS · Pharma > Pharmaceuticals & Drugs · Chairman: Prakash M Patil · MD: Rashesh C Gogri · Listing date: Sept. 12, 1996 · Employees: 1620 · Mumbai · http://www.aartidrugs.co.in

Stock Price vs Company Growth

0.9%

2.6%

5.3%

7.7%

4.2%

18.5%

11.7%

10y

12.7%

all

23.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 385 0.9%

344

407

Company Overview

Sales

2,565 Cr

Growth: 4.0%

Profit after Tax

195 Cr

Growth: -3.8%

Small Cap

3,514 Cr

P/E: 18.1x

Industry P/E: 33.7x

Fundamentals

Sales (Cr)	₹ 2,565
Growth	4.0%
EBITDA	12.1%
P/S	1.4x
Dividend	0.5%
P/E	18.1x
Book Value	₹ 10
PEG Ratio	4.4x
ROE	213.6%
P/B	N/A

Shareholding Pattern

Institutions

Harit Pragji Shah

2.65 %

Jayshree Harit Shah

1.79 %

Dsp Small Cap Fund

1.21 %

Promoters

Prakash Moreshwar Patil

9.1 %

Seema Harshit Savla

4.92 %

Harshit Manilal Savla

4.73 %

Rashesh Chandrakant Gogri

4.52 %

Priti Prakash Patil

4.4 %

Others

Iepf

0.3 %

Llp

0.08 %

Increase Decrease No change

Company Profile Detailed

The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.

Belongs to (11 Indices) view more

Investors (90)

chandrak...

harit.p....

dsp.blac...

Followers (7)

nitin2

keerthi

deepak